Which Biologic Is Best for My Condition?
A condition-by-condition pharmacist guide to help you understand your biologic options before your prescriber appointment.
The best biologic varies by condition, disease severity, and individual patient factors. BiologicHealthPlus pharmacists can review your insurance coverage, compare copay costs across all covered biologics, and help you prepare for a productive conversation with your prescriber about the best option for you.
Which Biologic Is Best: By Condition
Which biologic is best for psoriatic arthritis?
Cosentyx (secukinumab) and Tremfya (guselkumab) address both skin and joint disease in PsA. Rinvoq (upadacitinib) is particularly effective for active joint disease. Your rheumatologist considers skin involvement, dactylitis, enthesitis, and prior therapy.
Which biologic is best for asthma?
For severe eosinophilic asthma, Fasenra (benralizumab), Nucala (mepolizumab), and Dupixent (dupilumab) are highly effective. Xolair (omalizumab) is used for allergic asthma. Tezspire (tezepelumab) targets a broader asthma phenotype.
Which biologic is best for scalp psoriasis?
Biologics that target IL-17 (Cosentyx, Bimzelx) and IL-23 (Skyrizi, Tremfya) achieve high scalp clearance rates. Skyrizi shows particularly strong scalp psoriasis clearance data in clinical trials.
Which biologic is safest in pregnancy?
Cimzia (certolizumab pegol) is the most studied biologic in pregnancy and does not cross the placenta significantly due to its PEGylated structure. Enbrel and Humira cross the placenta in the third trimester. Always discuss pregnancy with your prescriber.
Which biologic is best for RA?
For rheumatoid arthritis, Rinvoq (upadacitinib), Humira (adalimumab), and Orencia (abatacept) demonstrate consistent efficacy. Actemra (tocilizumab) is particularly effective for elevated CRP. Your rheumatologist determines the best fit.
Which biologic is best for eczema?
Dupixent (dupilumab) is the most established biologic for moderate-to-severe atopic dermatitis with over 7 years of real-world data. Rinvoq and Cibinqo are JAK inhibitor alternatives for eczema.
Which biologic is best for hidradenitis suppurativa?
Bimzelx (bimekizumab) is the newest and highest-efficacy biologic for HS. Humira (adalimumab) was the first FDA-approved biologic for HS and remains widely used. Cosentyx is also approved for HS.
Which biologic works best for Crohn's?
Skyrizi (risankizumab) has demonstrated high clinical remission rates in Crohn's disease in the ADVANCE and MOTIVATE trials. Stelara and Entyvio also have strong Crohn's efficacy profiles.
Which biologic is best for ulcerative colitis?
Omvoh (mirikizumab) and Entyvio (vedolizumab) show strong UC remission data. Stelara, Humira, Remicade, and Rinvoq are also widely used. Your gastroenterologist determines the best option based on disease extent and severity.
Which biologic is best for ankylosing spondylitis?
Cosentyx (secukinumab) and Rinvoq (upadacitinib) are considered highly effective first-line biologics for AS. Humira, Enbrel, Remicade, Cimzia, and Simponi are also approved and widely used.
Have a question about your biologic?
Speak with a BiologicHealthPlus pharmacist 24/7Detailed Comparisons
Cosentyx (secukinumab) and Tremfya (guselkumab) address both skin and joint disease in PsA. Rinvoq (upadacitinib) is particularly effective for active joint disease. Your rheumatologist considers skin involvement, dactylitis, enthesitis, and prior therapy.
For severe eosinophilic asthma, Fasenra (benralizumab), Nucala (mepolizumab), and Dupixent (dupilumab) are highly effective. Xolair (omalizumab) is used for allergic asthma. Tezspire (tezepelumab) targets a broader asthma phenotype.
Biologics that target IL-17 (Cosentyx, Bimzelx) and IL-23 (Skyrizi, Tremfya) achieve high scalp clearance rates. Skyrizi shows particularly strong scalp psoriasis clearance data in clinical trials.
Cimzia (certolizumab pegol) is the most studied biologic in pregnancy and does not cross the placenta significantly due to its PEGylated structure. Enbrel and Humira cross the placenta in the third trimester. Always discuss pregnancy with your prescriber.
For rheumatoid arthritis, Rinvoq (upadacitinib), Humira (adalimumab), and Orencia (abatacept) demonstrate consistent efficacy. Actemra (tocilizumab) is particularly effective for elevated CRP. Your rheumatologist determines the best fit.
Dupixent (dupilumab) is the most established biologic for moderate-to-severe atopic dermatitis with over 7 years of real-world data. Rinvoq and Cibinqo are JAK inhibitor alternatives for eczema.
Bimzelx (bimekizumab) is the newest and highest-efficacy biologic for HS. Humira (adalimumab) was the first FDA-approved biologic for HS and remains widely used. Cosentyx is also approved for HS.
Skyrizi (risankizumab) has demonstrated high clinical remission rates in Crohn's disease in the ADVANCE and MOTIVATE trials. Stelara and Entyvio also have strong Crohn's efficacy profiles.
Omvoh (mirikizumab) and Entyvio (vedolizumab) show strong UC remission data. Stelara, Humira, Remicade, and Rinvoq are also widely used. Your gastroenterologist determines the best option based on disease extent and severity.
Cosentyx (secukinumab) and Rinvoq (upadacitinib) are considered highly effective first-line biologics for AS. Humira, Enbrel, Remicade, Cimzia, and Simponi are also approved and widely used.